The Association of Salvia divinorum and Psychotic Disorders: A Review of the Literature and Case Series

Loading...
Thumbnail Image

Date

Journal Title

Journal ISSN

Volume Title

Publisher

Routledge

Abstract

The association of substance abuse and psychotic disorders is of interest to clinicians, academics, and lawmakers. Commonly abused substances, such as cannabis, cocaine, amphetamines, and alcohol, have all been associated with substance-induced psychosis. Hallucinogens can induce desired psychedelic effects and undesirable psychomimetic reactions. These are usually transient and resolve once the duration of action is over. Sometimes, these effects persist, causing distress and requiring intervention. This article focuses on the hallucinogenic substance Salvia divinorum, the use of which has been observed, particularly among youth worldwide. We present background information based on a review of the literature and on our own clinical encounters, as highlighted by two original case reports. We hypothesize that consumption of Salvia divinorum could be associated with the development of psychotic disorders. We propose that clinicians routinely inquire about the use of Salvia in patients with substance use disorders or psychotic illnesses. More research is required to assess any relationship between Salvia divinorum and psychosis. Additionally, we advocate increased public and medical awareness of this substance and other emerging drugs of abuse. © 2015 Taylor & Francis Group, LLC.

Description

Keywords

Hallucinogen, Psychosis, Salvia divinorum, Salvinorin a, Substance-induced psychosis (sip), Hallucinogens, Humans, Male, Psychotic disorders, Salvia, Substance-related disorders, Young adult, 3,4 methylenedioxymethamphetamine, Alprazolam, Aripiprazole, Atomoxetine, Cannabinoid 1 receptor agonist, Cannabinoid 2 receptor agonist, Cannabis, Carbamazepine, Cocaine, Delta opiate receptor, Dopamine 2 receptor, Kappa opiate receptor, Lithium carbonate, Mu opiate receptor, Muscarinic receptor, N methyl dextro aspartic acid receptor, Olanzapine, Psychedelic agent, Risperidone, Serotonin 2 agonist, Sertraline, Valproic acid, Venlafaxine, Adult, Attention deficit disorder, Behavior change, Case report, Delusion, Depression, Dopamine brain level, Drug abuse, Drug dose increase, Drug substitution, Drug urine level, Drug withdrawal, Dystonia, Emergency ward, Follow up, Gastrointestinal symptom, Headache, Human, Hyperammonemia, Paranoia, Pathophysiology, Review, Rheumatic disease, Sedation, Side effect, Visual hallucination, Addiction, Adverse effects, Psychology

Citation

Collections

Endorsement

Review

Supplemented By

Referenced By